Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine vs Lithium in Bipolar II Depression
NCT00602537Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Dec 2007
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of venlafaxine in Bipolar II disorder (BP-II) (2 arms), sponsored by University of Pennsylvania. Primary endpoint: Depressive Relapse at 36 weeks. Started Dec 2007; status: completed.
02
Drugs
venlafaxine
03
Conditions
Bipolar II disorder (BP-II)
Beyond the preview
Go deeper on NCT00602537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00602537.